Volume 11 - Issue 3 - March, 2003
The Cardiovascular Technology Program at Grossmont College
- Thu, 6/19/08 - 2:00pm
- 0 Comments
- 8410 reads
Why and how did you become an educator?
I graduated from the Navy Cardiopulmonary School in Bethesda, Maryland in 1964. I served as a staff technologist at the Naval Medical Research Center at Bethesda, and later at the Naval Hospital in Portsmouth, Virginia. In 1971, I was assigned as the Senior Instructor in the Navy Cardiopulmonary School at the Naval Medical Center, San Diego. To prepare for that assignment, I attended a special course of instruction in the Techniques of Teaching and Naval Leadership.
While teaching in the Navy program, I discovered that, while I had always en
CEU OFFERING: Advances in Adjunctive Pharmacotherapy for Patients Undergoing PCI
- Thu, 6/19/08 - 2:00pm
- 0 Comments
- 6604 reads
Learning Objectives.
At the conclusion of this activity, the participant should be able to:
Explain how thrombi are generated and their role in acute coronary syndromes
Describe the multiple pathways leading to platelet activation
Define the role of different adjunctive therapies in inhibiting thrombus formation
Compare the efficacy and safety of different adjunctive therapies in patients undergoing percutaneous coronary intervention (PCI)
Activity instructions. Successful completion of this activity entails reading the article, answering the test
Letter to the Editor
- Thu, 6/19/08 - 2:00pm
- 0 Comments
- 709 reads
In response to the Letters to the Editor in the January issue of Cath Lab Digest (Laissez Faire Facilities and JCAHO & In Compliance with MIOSHA/OSHA?), our cath lab has never required the staff to wear hat/masks during LHC/interventions, only pacers, AICD, when there is an open wound. In our 10 year history we have not had any problems with increased infections in patients or staff exposure problems (we wear protective glasses). We do over 3000 cases a year, work with a dozen cardiologists.
This is not laissez faire attitude and we are not scrambling to meet standards. We have passe
What Do You Think?
- Thu, 6/19/08 - 2:00pm
- 0 Comments
- 3040 reads
Patient Follow Up
Our lab is going to start following patients after discharge to home. The plan is to call patients at home and ask them various questions about their post-hospital recovery period. We’d like to know what other labs do in regards to:
Follow up time-frame;
How they document these interviews;
What questions are asked during the interview;
Where is the data stored;
Who is responsible for accomplishing this (i.e. cath lab nurses/techs, clinic staff, same day admissions);
What is your staffing ratio;
How is time allotted to complete this task
Clinical Events Calendar
- Thu, 6/19/08 - 2:00pm
- 0 Comments
- 2150 reads
March 27 - 29
14th Annual ACCA Cardiovascular Administrators’ Management Conference
American College of Cardiovascular Administrators is a specialty group of the
American Academy of Medical Administrators Managing the Winds of Change: Evolution, Ethics and Economics
Location: Hyatt Regency
McCormick Place, Chicago, IL
Contact: info@aameda.org
Website: www.aameda.org
Immediately preceding the 52nd Annual Scientific Session of the American College of Cardiology, March 30-April 2
March 27 - 29
Miami International Revascularization Summit
Location: Wyndham Mi
Cath Lab Digest Email Discussion Group
- Thu, 6/19/08 - 2:00pm
- 0 Comments
- 1603 reads
The following Email Discussion Group was sponsored by the Society for Invasive Cardiovascular Professionals (SICP).
Does your hospital plan on stocking drug-eluting stents? If yes, will you have strict criteria for usage?
Patient Selection Criteria Under Discussion
We are going to begin performing interventions without surgery in January and have been watching the news very closely with regards to drug-eluting stents. We are hoping/planning to stock them when they become available. In our discussions with the physician who is coming as our interventionalist, we have
In Brief: Original Research Abstracts from the Journal of Invasive Cardiology
- Thu, 6/19/08 - 2:00pm
- 0 Comments
- 2978 reads
Safety and Efficacy of Cutting Balloon Angioplasty:The Mayo Clinic Experience
James L. Orford, MBChB, MPH, Panayotis Fasseas, MD, Ali E. Denktas, MD, LaVon Hammes, Kirk N. Garratt, MD, Peter B. Berger, MD, David R. Holmes, MD, Gregory W. Barsness, MD
From the Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota.
ABSTRACT: A number of evolving clinical indications for cutting balloon angioplasty (CBA) have been described in the clinical literature, including angioplasty-resistant stenoses, in-stent restenosis, ostial lesions and small vessel disease. Methods
Clinical and Industry News I
- Thu, 6/19/08 - 2:00pm
- 0 Comments
- 3489 reads
Boston Scientific Announces European Launch of Its TAXUS Paclitaxel-Eluting Stent System
Boston Scientific Corporation announced that it has initiated the launch of its TAXUS® paclitaxel-eluting stent system in Europe and other international markets. It plans to launch the product in the United States later this year.
The TAXUS product will use the Express2 coronary stent system as its platform. The Express2 system was launched in the United States in mid-September. Since then, Boston Scientific has approximately quadrupled its share of the U.S. stent market.
The TAXUS clini
Clinical and Industry News II
- Thu, 6/19/08 - 2:00pm
- 0 Comments
- 1367 reads
HIV Drugs Don’t Increase Heart Risk
Fears that the drugs used to treat people infected with HIV cause an increased risk of heart attack and stroke appear to be unfounded, at least over the short term, researchers report.
While it is possible there is a long-term risk, it is overwhelmed by the benefits of drug treatment, says study author Dr. Samuel A. Bozzette, director of health research at the San Diego Veterans Affairs Medical Center.
If you look at the total risk of death or heart attack, people will still be enormously better off with treatment, Bozzette says.
The
First Annual Ohio River Valley Cardiovascular Symposium is a Huge Success
- Thu, 6/19/08 - 2:00pm
- 0 Comments
- 3325 reads
What if you read comments like:
Excellent breakout sessions;
Symposium and entertainment were excellent; SICP should be commended;
Very well-planned and thought out;
I’ve attended these type of meetings in Cincinnati, Texas, Tennessee, and Indiana, and I feel this has been the most educational and excellent meeting I have been to in 10 years; you all are the GREATEST.;
Instructors are knowledgeable and personable?
These are the ratings and comments received from the attendees of the first annual Ohio River Valley Cardiovascular Symposium, sponsored by
- « Previous
- | Page 1 of 2 |
- Next »
